DPP4 Is a Potential Prognostic Marker of Thyroid Carcinoma and a Target for Immunotherapy
DPP4 (dipeptidyl peptidase 4) is expressed in many cancers, but the relationship between DPP4 and thyroid carcinoma (THCA) is incompletely understood. We aim to explore the expression of DPP4 in THCA and the correlation between DPP4 expression with the prognosis of THCA and antitumor immunity. We sy...
Saved in:
| Main Authors: | Xiaoqian Gao, Yali Le, Chenchen Geng, Zhen Jiang, Guanghui Zhao, Ping Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2022/5181386 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification of HES4 as a novel prognostic marker and therapeutic target in hepatocellular carcinoma
by: Yungang Liu, et al.
Published: (2025-02-01) -
NeSyDPP-4: discovering DPP-4 inhibitors for diabetes treatment with a neuro-symbolic AI approach
by: Delower Hossain, et al.
Published: (2025-07-01) -
DPP4 rs17574 polymorphism and elevated DPP4 levels linked to fatty liver in subclinical atherosclerosis: GEA study findings
by: Gilberto Vargas-Alarcón, et al.
Published: (2025-04-01) -
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01) -
FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma
by: Ting Shen, et al.
Published: (2022-01-01)